Stockreport

OS Therapies Provides OST-HER2 UK MHRA and US FDA Osteosarcoma Regulatory Update [Yahoo! Finance]

OS Therapies Incorporated  (OSTX) 
PDF following positive August 2025 Scientific Advice Meeting feedback from UK MHRA In principle, UK MHRA accepts use of historical control arm to support conditional MAA [Read more]